Recruiting

Yaari Extractor

Sponsor:

FetalEase Ltd.

Code:

NCT05913609

Conditions

Shoulder Dystocia

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Accepted

Interventions

Yaari Extractor

Study Details

Brief summary:

Prospective, multi-center, single arm with historical control, to verify the safety and effectiveness of the Yaari Extractor used by board certified or board eligible U.S. OB/GYN physicians in the management of shoulder dystocia.

Conditions

Shoulder Dystocia

Study ID

NCT05913609

Start date

Nov 15, 2023

Status verified date

Nov, 2025

Completion date

Apr, 2027

Anticipated

Primary completion date

Nov, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

1. Subject 18 years of age or older at time of consent.
2. Subject planning on vaginal birth.
3. Singleton pregnancy in vertex presentation.
4. Full-term pregnancy having completed 37 weeks or more gestational weeks.
5. Able and willing to provide written informed consent prior to enrollment.
6. In the opinion of the Investigator, the subject has sufficient mental capacity to understand the informed consent form (ICF).
7. Subject with fetus experiencing shoulder dystocia as defined by ACOG Practice Bulletin 178 "Shoulder dystocia is most commonly diagnosed as failure to deliver the fetal shoulder(s) with gentle downward traction on the fetal head, requiring additional maneuvers to effect delivery."

Exclusion Criteria:

1. Patients who have undergone attempted delivery using ancillary standard of care maneuvers, to include first-line maneuvers (McRoberts ± suprapubic pressure with downward traction on the fetal head), prior to use of the Yaari Extractor. (NOTE: Hyperflexion of the hips or legs is allowed prior to and during use of the Yaari Extractor.)
2. Cesarean section is planned for the patient.
3. Obstetric contraindications to vaginal birth.
4. Subject carrying fetus with known significant chromosomal or structural anomalies.
5. Clinically estimated fetal weight ≥5kg in non-diabetic subjects.
6. Clinically estimated fetal weight ≥4.5kg in subjects with diabetes.
7. Subject has any general health condition or systemic disease that may represent, in the opinion of the Investigator, a potential increased risk associated with device use or pregnancy.
8. Bleeding disorders, such as thrombocytopenia, von Willebrand's disease, bleeding disorder currently using anticoagulation medication, etc.
9. Any maternal disease or disorder that precludes the subject from pushing effectively.
10. If the maternal cervix is not fully dilated.
11. If the fetal head is not completely out of the birth canal.
12. In the presence of a non-reducible nuchal cord.

Study Design

Enrollment

80 participants

Anticipated

Allocation

Non randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Yaari Extractor group

Prospective experimental arm

no intervention: Control group

Historical control arm - retrospective review of medical records at the same study sites

Interventions

Yaari Extractor

The Yaari Extractor device is a single-use prescription device for neonatal extraction in deliveries that are complicated by shoulder dystocia. The Study Device consists of two curved, rigid plastic-coated metal Arms with Handles which are used for control of the device outside the body, and an elastic Engagement Element which conforms to the maternal and neonatal anatomy, and which is used for direct contact with the entrapped neonate within the birth canal.

Primary outcome measure

  • Number of successful neonate deliveries with the Yaari Extractor device [ Time Frame: immediately after the intervention ]
  • Time interval (minutes) from the diagnosis of the shoulder dystocia until the neonate's delivery [ Time Frame: immediately after the intervention ]
  • Maternal and neonatal adverse events [ Time Frame: through study completion, an average of 5 days ]

Central Contacts and Locations

Central contacts

Locations

University of Miami - Jackson Memorial

Recruiting

Miami, Florida, United States, 33136

Contacts

Jemima Duroseau, BSN, RN, MPH

305-689-8010jxp431@med.miami.edu

Principal Investigator:

Michael Paidas, MD

Rosemark WomenCare Specialist

Recruiting

Idaho Falls, Idaho, United States, 83404

Contacts

Principal Investigator:

Jason Gundersen, MD

Unified Women's Clinical Research

Recruiting

Winston-Salem, North Carolina, United States, 27103

Contacts

Principal Investigator:

Robert L Parker, MD

Inova Fairfax Medical Campus

Recruiting

Falls Church, Virginia, United States, 22042

Contacts

Principal Investigator:

Scott A Sullivan, MD

More Information

Sponsor

FetalEase Ltd.

Last update posted

Nov 25, 2025

Last verified

Nov, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by FetalEase Ltd. on 2025-11-25.